Our Team

Our Team

ENABLING BIOPHARMACEUTICAL COMPANIES TO DEVELOP BETTER TREATMENTS FOR NEURODEGENERATIVE DISEASES, FASTER

AxoSim has a diverse team of talented individuals spanning many disciplines. We pride ourselves on collaborating to solve problems in measurable ways, both internally and externally. We’re quality obsessed. We work tirelessly to help our pharmaceutical partners find the solutions they need to succeed, all while they learn to admire and respect our team, products, and solutions.

Lowry Curley, PhD

Lowry Curley, PhD

Chief Executive Officer

Lowry is co-founder and CEO of AxoSim. He drives the vision and implementation for product […]

Read More

Lowry is co-founder and CEO of AxoSim. He drives the vision and implementation for product development and commercialization of AxoSim’s NerveSim® and BrainSim® drug discovery platforms, with the goal of making a significant impact on medicine and patient care. Lowry received a PhD in biomedical engineering from Tulane University focused on tissue engineering and neuroscience. He is active on HESI’s (Health and Environmental Science Institute) Neutox Committee, which is a national nonprofit that works to resolve global health and environmental challenges through engagement of scientists from academia, government, industry, NGOs, and other strategic partners. Lowry is also an early member of the Nonclinical Innovation and Patient Safety Initiative collaboration (NIPSI) which advocates to the FDA for use of safer, more effective non-animal testing models in drug discovery. Locally, he serves on the New Orleans BioDistrict Board, dedicated to supporting economic growth of the biosciences sector in Southeast Louisiana.

Michael Moore, PhD

Michael Moore, PhD

Chief Science Officer

Michael is co-founder and CSO of AxoSim and an Associate Professor of Biomedical Engineering at […]

Read More

Michael is co-founder and CSO of AxoSim and an Associate Professor of Biomedical Engineering at Tulane University, with nearly 20 years of experience in biomaterials, neuroscience, and regenerative medicine. He received his PhD from the Mayo Clinic Graduate School of Biomedical Sciences, and has experience commercializing laboratory-based technology from there as well as from his postdoc with Prof. Robert Langer at MIT. AxoSim is one of three startups to begin in Michael’s lab, though it is the only company he maintains direct involvement.

Benjamin Cappiello

Benjamin Cappiello

Chief Business Officer

Ben leads the commercial side of AxoSim and was a founding advisor to the company […]

Read More

Ben leads the commercial side of AxoSim and was a founding advisor to the company before joining full time in 2017. He is an entrepreneur and biomedical engineer. After graduating from Tulane’s biomedical engineering program, he founded Bioceptive, a women’s health company where he remains the CEO, splitting his time with AxoSim. Ben is also the Vice President-Elect of the North American 3R’s Collaborative, focused on reducing the amount of ineffective animal testing done in pharmaceutical development.

Thomas Hartung, MD, PhD

Thomas Hartung, MD, PhD

Consulting VP of Scientific Affairs

Thomas Hartung, MD PhD, is AxoSim’s Consulting VP of Scientific Affairs and the inventor of […]

Read More

Thomas Hartung, MD PhD, is AxoSim’s Consulting VP of Scientific Affairs and the inventor of the Mini-Brain platform. Thomas believed in AxoSim’s vision to change the paradigm for neurological drug development and chose AxoSim to commercialize his groundbreaking technology. He is also the Doerenkamp-Zbinden-Chair for Evidence-based Toxicology at Johns Hopkins Bloomberg School of Public Health and the Whiting School of Engineering, Baltimore, in Environmental Health and Engineering. He is also the Director of Centers for Alternatives to Animal Testing (CAAT, http://caat.jhsph.edu) of both Hopkins and the University of Konstanz, Germany. CAAT hosts the secretariat of the Evidence-based Toxicology Collaboration, the Good Read-Across Practice Collaboration, the Good Cell Culture Practice Collaboration, the Green Toxicology Collaboration and the Industry Refinement Working Group. He is the former Head of the European Commission’s Center for the Validation of Alternative Methods (ECVAM), Ispra, Italy, and has authored more than 550 scientific publications.

Monica Metea, PhD

Monica Metea, PhD

VP Operations

Dr. Monica Metea founded Preclinical Electrophysiology Consulting (PCEC), a company supporting biotech, pharma and CROs […]

Read More

Dr. Monica Metea founded Preclinical Electrophysiology Consulting (PCEC), a company supporting biotech, pharma and CROs with drug safety projects and electrophysiology-focused applications. These include electroencephalography and neurography in support of preclinical derisking, in vitro screening, organ-on-a-chip model development, safety pharmacology core battery, and computational approaches to data. Monica’s background spans three decades of cross disciplinary life sciences including clinical electrophysiology, doctoral studies in neuroscience at the University of Minnesota, and industry experience in preclinical drug development. Before starting PCEC, Monica held strategic business leadership roles in contract research organizations providing in vivo and in vitro services to the non-clinical pharmaceutical and agrochemical sector.

Anup Sharma, PhD

Anup Sharma, PhD

Research Scientist II

Anup is responsible for developing complex 2D and 3D in vitro models of the nervous […]

Read More

Anup is responsible for developing complex 2D and 3D in vitro models of the nervous system using standard tissue culture principles and AxoSim’s proprietary NerveSim® and BrainSim® platforms. He graduated from the Indian Institute of Technology Madras and worked in the tech industry before pursuing his PhD in Chemical and Biological Engineering from Iowa St. University. Anup’s interests focus on synergistically combining engineering methods with biological processes in vitro to develop products with implications in drug screening, disease modeling, regenerative medicine, and toxicology. Anup joined AxoSim to apply his expertise to commercial translation.

Wesley Anderson, PhD

Wesley Anderson, PhD

Research Scientist II

Wesley is working on the development of 3D neural tissue models and analysis techniques, including […]

Read More

Wesley is working on the development of 3D neural tissue models and analysis techniques, including AxoSim’s proprietary BrainSim® and NerveSim® platforms. He graduated from the University of Central Florida with a PhD in Biomedical Sciences, focusing on the development of an in vitro functional 3D model of the peripheral nerve. He specializes in tissue engineering and regenerative medicine as well as neuroscience.

Corey Rountree, PhD

Corey Rountree, PhD

Research Scientist II

Corey leads the development of the NerveSim® platform, focusing on increasing throughput through automation of […]

Read More

Corey leads the development of the NerveSim® platform, focusing on increasing throughput through automation of electrophysiological recording and analysis. He received his PhD in Biomedical Engineering from Northwestern University, characterizing electrophysiological recordings and determining the feasibility of single-site neurotransmitter-based stimulation for treating photoreceptor degenerative diseases. His postdoctoral work furthered his research through the development of a prototype multiport neurotransmitter-based retinal prosthesis using photolithography. Corey specializes in electrophysiology, photolithography, and data analysis.

Lise Harbom, PhD

Lise Harbom, PhD

Post-Doctoral Researcher

Lise received a B.A. in Neuroscience from Vanderbilt University and a Ph.D. in Neuroscience from […]

Read More

Lise received a B.A. in Neuroscience from Vanderbilt University and a Ph.D. in Neuroscience from the University of Virginia, focusing on electrophysiology in iPSC-derived neurons.  She is interested in the translational potential of using cell models for drug screening.   Currently, Lise is using the NerveSim™ technology to create a human cell-based model of amyotrophic lateral sclerosis (ALS).

Megan Morris, MSE

Megan Morris, MSE

Director of Operations

Megan manages AxoSim operations with an emphasis on commercial activities and the integration of both […]

Read More

Megan manages AxoSim operations with an emphasis on commercial activities and the integration of both quality management and HSSE (health, safety, security, and environmental) management. She earned her master’s degree in Biomedical Engineering from Tulane University and comes to us with a wide range of organizational experience from various industries. She is committed to ensuring AxoSim delivers robust data to clients with quality, integrity, and reliability.

Jeff Karlson

Jeff Karlson

Finance & Administration Manager

Jeff manages accounting and administration at AxoSim. He comes to us from the nonprofit arena […]

Read More

Jeff manages accounting and administration at AxoSim. He comes to us from the nonprofit arena where he spent many years working in project, grant, and financial management on a host of local and national efforts. Most recently he provided financial and grants management oversight for a local non-profit’s 5-year, $4 million contract under the Gulf Region Health Outreach Program, part of a four-state project to expand health care access along the Gulf Coast.

Adam Julien, MSc.

Adam Julien, MSc.

Operations Associate

Adam works with the Operational Leadership team developing processes involving inventory management and systems building. […]

Read More

Adam works with the Operational Leadership team developing processes involving inventory management and systems building. He comes to AxoSim with a varied background in customer service, healthcare, and museum programming. He received his Masters degree in cognitive and clinical neuroscience from Goldsmiths University in London, England. He is a proud New Orleans native and a devoted Saints fan.

Laurie McCoy, MSc

Laurie McCoy, MSc

Research Associate III

Laurie’s current efforts are working on the genetic expression of neurodegenerative diseases and image analysis. […]

Read More

Laurie’s current efforts are working on the genetic expression of neurodegenerative diseases and image analysis. She received a master’s degree in biomedical sciences and pharmaceuticals from the University of Strathclyde in Glasgow, Scotland. Laurie is a proud native of Louisiana and a graduate of Southeastern Louisiana University.

Megan Terral

Megan Terral

Project Manager

Megan is currently focused on demyelination and neuropathy studies at AxoSim. She received an undergraduate […]

Read More

Megan is currently focused on demyelination and neuropathy studies at AxoSim. She received an undergraduate degree in biochemical engineering from the University of Georgia, where she grew interested in tissue engineering, biomaterials, and translational research. In the future, she plans to pursue either a PhD or an MD.

Don Seyfried, MS

Don Seyfried, MS

Research Assistant III

Don received his MS in Neuroscience from University at Buffalo while studying the effect of diabetes […]

Read More

Don received his MS in Neuroscience from University at Buffalo while studying the effect of diabetes on the retina. Previous experience with glial cell types and their role in repair of the brain after stroke gives him insight into AxoSim’s co-culture models. By focusing on molecular signal transduction and energy metabolism, he hopes to contribute to assay development for these in vitro brain models.

Tarra Sanders, MS

Tarra Sanders, MS

Research Assistant III

Tarra received a Master’s degree in Biomedical Engineering from California Polytechnic State University. Her research […]

Read More

Tarra received a Master’s degree in Biomedical Engineering from California Polytechnic State University. Her research focused on microfluidic cell culture and electrochemical impedance spectroscopy. She is passionate about the revolutionary work being done at AxoSim, and is excited for the future of the company.

Eva Schmidt

Eva Schmidt

Research Assistant II

Eva earned her degree in Biological Engineering at Louisiana State University. While there, she found […]

Read More

Eva earned her degree in Biological Engineering at Louisiana State University. While there, she found a passion for biomedical research with a background in oxidative stress and diabetic kidney disease research. At AxoSim, she assists in neuropathy, myelination studies, and  commercialization. Eva is most interested in the novel biotechnology and innovative molecular methods AxoSim offers.

Gina Jackson

Gina Jackson

Executive Assistant to CEO

Gina Marie is an experienced former Director of Communications, skilled in project management, public relations, […]

Read More

Gina Marie is an experienced former Director of Communications, skilled in project management, public relations, event planning, and investor relations. Gina holds a Bachelor of Science in Communication from the University of Miami.

Elizabeth Thiebaud

Elizabeth Thiebaud

Executive Assistant to CBO

Liz is a highly efficient and results-driven individual with over 15 years’ experience in professional […]

Read More

Liz is a highly efficient and results-driven individual with over 15 years’ experience in professional executive assistant and management positions.  Her background includes working with executives in business development, customer service, procedures and policies, staff management, employee relations, human resources, and accounting.

Diego Gatica

Diego Gatica

Database Intern

Diego is involved in building databases and streamlining data management at AxoSim. He is a […]

Read More

Diego is involved in building databases and streamlining data management at AxoSim. He is a master’s student in Biomedical Engineering at Tulane University, where he has been involved in reproductive health research and data management. He is most passionate about how innovative technologies can be implemented to improve the efficiency and effectiveness of healthcare.

AxoSim Alumni

AxoSim team members have gone on to do great things. We value personnel and professional development. We pride ourselves on offering a launching pad to fantastic scientific and entrepreneurial careers. We provide and encourage opportunities for growth including presentations at conferences, publications, journal clubs, and teaching modules.